Evgenia Michalcuk-Vráblík, Director, Business Development and MarketingWith more pharma clients seeking hyper-configurable solutions today, the no-code platform enables a quick and efficient configuration of the system without requiring modifications to internal processes or standard operating procedures (SOP). This flexibility ensures clients can maintain a competitive edge as it increases the system’s responsiveness to evolving needs and streamlines decision-making processes, resulting in enhanced operational efficiency.
It also benefits in mitigating resource and development costs. “As the industry continues to witness rising costs and challenges in hiring skilled developers, having a no-code approach empowers even clients themselves, as well as our project managers and analysts to handle system configurations, significantly increasing the nimbleness of clinical trial management processes,” says Evgenia Michalcuk-Vráblík, director of business development and marketing at Flex Databases.
Embracing Flexibility and Efficiency from Within
Flex Databases takes great pride in the fact that its no-code platform is developed entirely in-house, without relying on additional third-party platforms or solutions like Salesforce. The entire system, including its engine, is meticulously crafted by its engineers. This end-to-end approach grants complete control over its development process, ensuring a cohesive and seamless solution that caters to specific client needs.
The engine acts as the robust back-end of its no-code and flexible experience. Built upon this technical foundation is the compliance-validated no-code platform with a diverse range of modules. These modules include essential components such as the Electronic Trial Master File (eTMF), quality management system, learning management system, clinical operations activities management, budgets and payments management, and safety database.
Each module further segments into various functions. For instance, in the eTMF module, clients are greeted with a preconfigured structure, including placeholders, document templates, and a well-defined metadata structure. On the other hand, the quality management system encompasses workflows used for corrective and preventive actions (CAPA) management, audits, vendor qualification, SOP management, and batch management.
Clients are granted the autonomy to reconfigure these processes to precisely align with their specific requirements and policies. This exceptional level of flexibility permeates throughout all modules and sub-functions, fostering a truly customized and efficient clinical trial management experience.
Strong Partnerships through Collaborative Sales and Streamlined Implementation
Prioritizing client needs and problem-solving lays the foundation of Flex Databases’ sales process. Its focus is not solely on hitting financial targets but on understanding and addressing specific client requirements to make a meaningful impact on their clinical trial management journey.
A streamlined implementation process sets the stage for a seamless experience right from the start. During the initial weeks of implementation, the operations team, equipped with the knowledge obtained during the sales process, works with project managers to ensure a smooth transition.
To ensure compliance for GxP system modules, clients go through user acceptance testing scenarios guided by Flex Databases team, providing clear instructions and actively assisting clients throughout the end-user validation process. For instance, eTMF end-user validation part can be completed within two meetings of two hours each. While validation remains a crucial phase, the streamlined approach makes it far more manageable and efficient than traditional methods. In several weeks, including a full validation process, clients are equipped with a fully compliant system.
In February, Flex Databases undertook an implementation project for a Palo Alto-based biotech company, Irenix Medical, that was completed within a remarkably short period of three weeks. Not only did it deliver the complete eTMF system to production, including all the necessary structures, placeholders, and templates, it went beyond and provided an extended package of documents, including SOPs for eTMF management. Client team was happy with such a turn-key approach, as well as its on time delivery.
Success Rooted in its Talented Team
Flex Databases has achieved remarkable success by harmoniously integrating three crucial components. First, its top managers bring a wealth of industry expertise, stemming from their backgrounds as global CEOs and pharmaceutical industry veterans. This deep understanding of the field allows the firm to develop solutions that cater specifically to the needs of the clinical industry.
While maintaining compliance, data quality, and cost reduction remain fundamental clinical trial management goals, Flex Databases brings a new level of ease and agility to this approach with its user-friendly no-code platform
Another key pillar of its success lies in its customer success team, which provides extensive support to clients. This dedicated team nurtures long-term partnerships. The emotional intelligence exhibited by the team is pivotal in delivering exceptional services and ensuring successful client implementations.
“Our remarkable client retention rate speaks volumes about the enduring relationships we have cultivated. Clients who signed contracts with us as far back as 2011 continue to be our valued partners. Despite being a relatively small company, we already have a diverse client base of 100 organizations on our platform,” says Michalcuk-Vráblík, highlighting the trust clients place on Flex Databases.
Continuing Innovation and Focus on Data Intelligence
The firm is excited to announce the recently released out-of-the-box version of its quality management system with a range of new features and enhancements.
As Flex Databases progresses through this year, its focus remains steadfast on providing a comprehensive overview and a powerful data house for clients. Its built-in business intelligence (BI) tool, or the Reports Tool, plays a vital role in achieving this objective. To further empower clients, it is launching a library of 50 key performance indicators (KPIs) for each project, as well as cross-project analysis capabilities to manage its entire portfolio. This increased data visibility and reporting functionality will be a key focus for the firm, enabling its clients to make informed decisions based on comprehensive insights.
In addition to data intelligence, it is placing significant emphasis on the integration of risk management elements across all aspects of its system. Flex Databases’ QMS will serve as the central hub for effective risk management, providing a comprehensive framework to identify, assess, and mitigate risks across and beyond the clinical trial process.
Driven by these strategic updates and an unwavering commitment to drive the future of clinical trial management, Flex Databases remains poised to keep blazing new trails in the domain.


